nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Cystitis haemorrhagic—Epirubicin—peripheral nervous system neoplasm	0.0313	0.0313	CcSEcCtD
Clavulanate—Cystitis haemorrhagic—Doxorubicin—peripheral nervous system neoplasm	0.0289	0.0289	CcSEcCtD
Clavulanate—Induration—Etoposide—peripheral nervous system neoplasm	0.025	0.025	CcSEcCtD
Clavulanate—Swelling—Tretinoin—peripheral nervous system neoplasm	0.0156	0.0156	CcSEcCtD
Clavulanate—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.0156	0.0156	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Tretinoin—peripheral nervous system neoplasm	0.0124	0.0124	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Isotretinoin—peripheral nervous system neoplasm	0.0124	0.0124	CcSEcCtD
Clavulanate—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.0118	0.0118	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Tretinoin—peripheral nervous system neoplasm	0.0105	0.0105	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Isotretinoin—peripheral nervous system neoplasm	0.0105	0.0105	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Dactinomycin—peripheral nervous system neoplasm	0.0101	0.0101	CcSEcCtD
Clavulanate—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.00963	0.00963	CcSEcCtD
Clavulanate—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.00958	0.00958	CcSEcCtD
Clavulanate—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.00955	0.00955	CcSEcCtD
Clavulanate—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.00955	0.00955	CcSEcCtD
Clavulanate—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.00951	0.00951	CcSEcCtD
Clavulanate—Hepatitis—Tretinoin—peripheral nervous system neoplasm	0.00951	0.00951	CcSEcCtD
Clavulanate—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.00951	0.00951	CcSEcCtD
Clavulanate—Hepatitis—Isotretinoin—peripheral nervous system neoplasm	0.00951	0.00951	CcSEcCtD
Clavulanate—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.00943	0.00943	CcSEcCtD
Clavulanate—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.00938	0.00938	CcSEcCtD
Clavulanate—Hepatitis—Melphalan—peripheral nervous system neoplasm	0.00938	0.00938	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Alitretinoin—peripheral nervous system neoplasm	0.00938	0.00938	CcSEcCtD
Clavulanate—Swelling—Etoposide—peripheral nervous system neoplasm	0.00921	0.00921	CcSEcCtD
Clavulanate—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.00899	0.00899	CcSEcCtD
Clavulanate—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.00899	0.00899	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Dactinomycin—peripheral nervous system neoplasm	0.00858	0.00858	CcSEcCtD
Clavulanate—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.00807	0.00807	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00796	0.00796	CcSEcCtD
Clavulanate—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.00777	0.00777	CcSEcCtD
Clavulanate—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00747	0.00747	CcSEcCtD
Clavulanate—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.00735	0.00735	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.00732	0.00732	CcSEcCtD
Clavulanate—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00731	0.00731	CcSEcCtD
Clavulanate—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00724	0.00724	CcSEcCtD
Clavulanate—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.0072	0.0072	CcSEcCtD
Clavulanate—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.0072	0.0072	CcSEcCtD
Clavulanate—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00717	0.00717	CcSEcCtD
Clavulanate—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00717	0.00717	CcSEcCtD
Clavulanate—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.00714	0.00714	CcSEcCtD
Clavulanate—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00708	0.00708	CcSEcCtD
Clavulanate—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00681	0.00681	CcSEcCtD
Clavulanate—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00681	0.00681	CcSEcCtD
Clavulanate—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00675	0.00675	CcSEcCtD
Clavulanate—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00675	0.00675	CcSEcCtD
Clavulanate—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00667	0.00667	CcSEcCtD
Clavulanate—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00667	0.00667	CcSEcCtD
Clavulanate—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00661	0.00661	CcSEcCtD
Clavulanate—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00661	0.00661	CcSEcCtD
Clavulanate—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.00661	0.00661	CcSEcCtD
Clavulanate—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00653	0.00653	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00621	0.00621	CcSEcCtD
Clavulanate—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00605	0.00605	CcSEcCtD
Clavulanate—Pain—Topotecan—peripheral nervous system neoplasm	0.00582	0.00582	CcSEcCtD
Clavulanate—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00577	0.00577	CcSEcCtD
Clavulanate—Pain—Tretinoin—peripheral nervous system neoplasm	0.00577	0.00577	CcSEcCtD
Clavulanate—Pain—Melphalan—peripheral nervous system neoplasm	0.0057	0.0057	CcSEcCtD
Clavulanate—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00543	0.00543	CcSEcCtD
Clavulanate—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00541	0.00541	CcSEcCtD
Clavulanate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00541	0.00541	CcSEcCtD
Clavulanate—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.0054	0.0054	CcSEcCtD
Clavulanate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00536	0.00536	CcSEcCtD
Clavulanate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00536	0.00536	CcSEcCtD
Clavulanate—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00532	0.00532	CcSEcCtD
Clavulanate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0053	0.0053	CcSEcCtD
Clavulanate—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.00526	0.00526	CcSEcCtD
Clavulanate—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00524	0.00524	CcSEcCtD
Clavulanate—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00512	0.00512	CcSEcCtD
Clavulanate—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00502	0.00502	CcSEcCtD
Clavulanate—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00501	0.00501	CcSEcCtD
Clavulanate—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00498	0.00498	CcSEcCtD
Clavulanate—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00498	0.00498	CcSEcCtD
Clavulanate—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00493	0.00493	CcSEcCtD
Clavulanate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00491	0.00491	CcSEcCtD
Clavulanate—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00487	0.00487	CcSEcCtD
Clavulanate—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00483	0.00483	CcSEcCtD
Clavulanate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00482	0.00482	CcSEcCtD
Clavulanate—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00478	0.00478	CcSEcCtD
Clavulanate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00478	0.00478	CcSEcCtD
Clavulanate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00478	0.00478	CcSEcCtD
Clavulanate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00472	0.00472	CcSEcCtD
Clavulanate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00472	0.00472	CcSEcCtD
Clavulanate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00466	0.00466	CcSEcCtD
Clavulanate—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00463	0.00463	CcSEcCtD
Clavulanate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00462	0.00462	CcSEcCtD
Clavulanate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00462	0.00462	CcSEcCtD
Clavulanate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00456	0.00456	CcSEcCtD
Clavulanate—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00438	0.00438	CcSEcCtD
Clavulanate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00438	0.00438	CcSEcCtD
Clavulanate—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00436	0.00436	CcSEcCtD
Clavulanate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00433	0.00433	CcSEcCtD
Clavulanate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00429	0.00429	CcSEcCtD
Clavulanate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00429	0.00429	CcSEcCtD
Clavulanate—Rash—Topotecan—peripheral nervous system neoplasm	0.00429	0.00429	CcSEcCtD
Clavulanate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00429	0.00429	CcSEcCtD
Clavulanate—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Clavulanate—Rash—Tretinoin—peripheral nervous system neoplasm	0.00426	0.00426	CcSEcCtD
Clavulanate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00426	0.00426	CcSEcCtD
Clavulanate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00425	0.00425	CcSEcCtD
Clavulanate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00425	0.00425	CcSEcCtD
Clavulanate—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00424	0.00424	CcSEcCtD
Clavulanate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00424	0.00424	CcSEcCtD
Clavulanate—Pain—Vincristine—peripheral nervous system neoplasm	0.00422	0.00422	CcSEcCtD
Clavulanate—Rash—Melphalan—peripheral nervous system neoplasm	0.0042	0.0042	CcSEcCtD
Clavulanate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0042	0.0042	CcSEcCtD
Clavulanate—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00415	0.00415	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.0041	0.0041	CcSEcCtD
Clavulanate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00407	0.00407	CcSEcCtD
Clavulanate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00407	0.00407	CcSEcCtD
Clavulanate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00404	0.00404	CcSEcCtD
Clavulanate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00401	0.00401	CcSEcCtD
Clavulanate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00401	0.00401	CcSEcCtD
Clavulanate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00399	0.00399	CcSEcCtD
Clavulanate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00396	0.00396	CcSEcCtD
Clavulanate—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00391	0.00391	CcSEcCtD
Clavulanate—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.0039	0.0039	CcSEcCtD
Clavulanate—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00384	0.00384	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Clavulanate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00378	0.00378	CcSEcCtD
Clavulanate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Clavulanate—Pain—Cisplatin—peripheral nervous system neoplasm	0.00373	0.00373	CcSEcCtD
Clavulanate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Clavulanate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00362	0.00362	CcSEcCtD
Clavulanate—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Clavulanate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00351	0.00351	CcSEcCtD
Clavulanate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0035	0.0035	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Clavulanate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Clavulanate—Pain—Etoposide—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Clavulanate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Clavulanate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Clavulanate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Clavulanate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Clavulanate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00322	0.00322	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00322	0.00322	CcSEcCtD
Clavulanate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Clavulanate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Clavulanate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Clavulanate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00315	0.00315	CcSEcCtD
Clavulanate—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00315	0.00315	CcSEcCtD
Clavulanate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Clavulanate—Rash—Vincristine—peripheral nervous system neoplasm	0.00311	0.00311	CcSEcCtD
Clavulanate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00311	0.00311	CcSEcCtD
Clavulanate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Clavulanate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Clavulanate—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Clavulanate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Clavulanate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Clavulanate—Nausea—Vincristine—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Clavulanate—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Clavulanate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Clavulanate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Clavulanate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00277	0.00277	CcSEcCtD
Clavulanate—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Clavulanate—Rash—Cisplatin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Clavulanate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Clavulanate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Clavulanate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Clavulanate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Clavulanate—Rash—Etoposide—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Clavulanate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Clavulanate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Clavulanate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Clavulanate—Nausea—Etoposide—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Clavulanate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Clavulanate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Clavulanate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Clavulanate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Clavulanate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Clavulanate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Clavulanate—Pain—Epirubicin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Clavulanate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Clavulanate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Clavulanate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Clavulanate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Clavulanate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Clavulanate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Clavulanate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Clavulanate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Clavulanate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Clavulanate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Clavulanate—Rash—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Clavulanate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Clavulanate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Clavulanate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Clavulanate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Clavulanate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Clavulanate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
